Skip to content

HYDROmed BLUE drops in everyday life

HYDROmed BLUE drops in everyday life - AT-HBATIA

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00020912
Enrollment
35
Registered
2020-04-14
Start date
2019-11-22
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

H04.1

Interventions

Group 1: HYDROmed BLUE drops (3 - 5 times a day) for 4 weeks / 28 days

Sponsors

Dr. Theiss Naturwaren GmbH
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: • Dry eye due to external influences such as: - heating air, air conditioning - wind, cold or heat stimuli - Eye fatigue from computer workstations, computer games, smartphones • reactions caused by taking medication that can lead to dry eyes, - acetylsalicylic acid (for pain, to thin the blood) - anticholinergics (for colic or chronic bronchitis) - beta-blockers (for high blood pressure, irregular heartbeat, fast pulse) - Ergotamine (for migraines) - isotretinoin (for skin diseases such as acne) - neuroleptics (for psychoses) - estrogens (for menopause symptoms) - reserpine (for arterial hypertension) - thiazide diuretics (for increased blood pressure, edema) - tri- and tetracyclic antidepressants (for depressive disorders, anxiety)

Exclusion criteria

Exclusion criteria: • eye inflammation (bacterial or viral) • Eye surgery (in the past 6 weeks) • all medications that could influence the course of the study (e.g. antihistamines) • Autoimmune diseases • Pregnancy and breast feeding period • Use of contact lenses during the study • Known intolerance of an ingredient in the HYDROmed BLUE drops

Design outcomes

Primary

MeasureTime frame
Bulbar degree of redness, non-invasive R-Scan measurement: Evaluation of the whitening of the eyes after 0, 14 and 28 days.

Secondary

MeasureTime frame
Determination of eye moisture after 0, 14 and 28 days via NIKBUT: Determination of the wetting time after blinking and LIPCOF: Assessment of the direct eye area between the eyelids and conjunctiva such as Determination of visual acuity and product safety (recording of adverse events and horn skin examinations)

Countries

Germany

Contacts

Public ContactUlrike Heinrich

Derma Tronnier GmbH & Co. KG Institut für experimentielle Dermatologie

Ulrike.Heinrich@uni-wh.de+49 2302 2826 300

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026